Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNS-7801 in Parkinson's Disease
NCT03306329Phase 2Terminated
- Sponsor
- Dart NeuroScience LLC
- Start
- Sep 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DNS-7801 in Parkinson's disease (PD), sponsored by Dart NeuroScience LLC. Started Sep 2017; status: terminated.
02
Drugs
DNS-7801
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03306329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03306329.